A detailed history of Wells Fargo & Company transactions in Morpho Sys Ag stock. As of the latest transaction made, Wells Fargo & Company holds 400 shares of MOR stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400
Previous 2,088 80.84%
Holding current value
$0
Previous $37,000 81.08%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$17.36 - $19.34 $29,303 - $32,645
-1,688 Reduced 80.84%
400 $7,000
Q1 2024

May 10, 2024

SELL
$8.6 - $18.18 $5,684 - $12,016
-661 Reduced 24.05%
2,088 $37,000
Q4 2023

Feb 09, 2024

SELL
$4.55 - $9.9 $234,320 - $509,840
-51,499 Reduced 94.93%
2,749 $27,000
Q3 2023

Nov 13, 2023

BUY
$6.72 - $8.6 $39,755 - $50,877
5,916 Added 12.24%
54,248 $364,000
Q2 2023

Aug 15, 2023

BUY
$3.95 - $7.74 $190,911 - $374,089
48,332 New
48,332 $361,000
Q4 2022

Feb 13, 2023

SELL
$3.21 - $5.74 $1,412 - $2,525
-440 Reduced 77.74%
126 $0
Q3 2022

Nov 14, 2022

SELL
$4.14 - $22.13 $1,159 - $6,196
-280 Reduced 33.1%
566 $3,000
Q2 2022

Aug 12, 2022

BUY
$4.51 - $7.39 $1,262 - $2,069
280 Added 49.47%
846 $4,000
Q1 2022

May 16, 2022

SELL
$5.87 - $9.73 $14,463 - $23,974
-2,464 Reduced 81.32%
566 $4,000
Q4 2021

Feb 14, 2022

BUY
$9.08 - $12.45 $8,217 - $11,267
905 Added 42.59%
3,030 $28,000
Q3 2021

Nov 15, 2021

SELL
$11.76 - $19.51 $110,144 - $182,730
-9,366 Reduced 81.51%
2,125 $25,000
Q2 2021

Aug 16, 2021

BUY
$18.95 - $23.95 $190,978 - $241,368
10,078 Added 713.23%
11,491 $221,000
Q1 2021

May 13, 2021

SELL
$21.56 - $30.66 $14,897 - $21,186
-691 Reduced 32.84%
1,413 $31,000
Q4 2020

Feb 09, 2021

BUY
$24.81 - $30.33 $124 - $151
5 Added 0.24%
2,104 $60,000
Q3 2020

Nov 05, 2020

BUY
$30.28 - $35.72 $968 - $1,143
32 Added 1.55%
2,099 $66,000
Q2 2020

Aug 13, 2020

BUY
$24.08 - $33.35 $13,581 - $18,809
564 Added 37.52%
2,067 $65,000
Q1 2020

May 14, 2020

BUY
$18.86 - $37.36 $28,346 - $56,152
1,503 New
1,503 $37,000

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.